4 – 6/09/2025

Elite City Resort, Kalamata

IASIS PHARMA participated at the “18th Panhellenic Conference on Cardiometabolic Risk Factors”, held exclusively in person at the Elite City Resort Hotel/Kalamata, from September 4 to 6, 2025.

In IASIS PHARMA exhibition stand, the following products were presented:

  • RosuZet®: New Product Launching. Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single dosage form, in packages of  30 f.c. tabs available in the full spectrum of strengths:
    (Rosuvastatin / Ezetimibe)
    – 5 / 10mg
    – 10 /10mg,
    – 20 / 10mg,
    – 40 /10mg.
  • Rami–Amlo®, a fixed-dose combination of Ramipril & Amlodipine in a single dosage form, in packages of 28 capsules, available in 4 strengths:
    – 5mg/5mg,
    – 5mg/10mg,
    – 10mg/5mg,
    – 10mg/10mg.
  • Rami–Amlo plus®, also an original fixed-dose combination of Ramipril – Amlodipine –Hydrochlorothiazide, which is available in packages of 30 capsules, in a wide range of strengths:
    – 5 mg / 5 mg / 12,5 mg,
    – 5 mg / 5 mg / 25 mg,
    – 10 mg / 5 mg / 25 mg,
    – 10 mg / 10 mg / 25 mg
  • MAG–IASIS®, the first uniquely effective combination of 1193.57 mg Magnesium citrate & 667.56 mg Magnesium aspartate, equivalent to 243 mg Magnesium, indicated for magnesium deficiency, in the  form of 40 effervescent tablets.

 

stand Iasis Pharma